Interrater Reliability in the Measurement of Flow Characteristics on Color-Coded Quantitative DSA of Brain AVMs

References

1. 1.↵
   1. Brown RD,
   2. Wiebers DO,
   3. Torner JC, et al

   . Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted County, Minnesota. J Neurosurg 1996;85:29–32 doi:10.3171/jns.1996.85.1.0029 pmid:8683279

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Brown RD,
   2. Wiebers DO,
   3. Forbes G, et al

   . The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 1988;68:352–57 doi:10.3171/jns.1988.68.3.0352 pmid:3343606

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Graf CJ,
   2. Perret GE,
   3. Torner JC

   . Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg 1983;58:331–37 doi:10.3171/jns.1983.58.3.0331 pmid:6827317

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Morris Z,
   2. Whiteley WN,
   3. Longstreth WT, et al

   . Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2009;339:b3016 doi:10.1136/bmj.b3016 pmid:19687093

   Abstract/FREE Full Text
5. 5.↵
   1. Derdeyn CP,
   2. Zipfel GJ,
   3. Albuquerque FC, et al

   ; American Heart Association Stroke Council. Management of Brain Arteriovenous Malformations: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2017;48:e200–24 doi:10.1161/STR.0000000000000134 pmid:28642352

   CrossRefPubMed
6. 6.↵
   1. Mohr JP,
   2. Parides MK,
   3. Stapf C, et al

   ; International ARUBA investigators. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014;383:614–21 doi:10.1016/S0140-6736(13)62302-8 pmid:24268105

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Alexander MD,
   2. Cooke DL,
   3. Nelson J, et al

   . Association between venous angioarchitectural features of sporadic brain arteriovenous malformations and intracranial hemorrhage. AJNR Am J Neuroradiol 2015;36:949–52 doi:10.3174/ajnr.A4224 pmid:25634722

   Abstract/FREE Full Text
8. 8.↵
   1. Sahlein DH,
   2. Mora P,
   3. Becske T, et al

   . Features predictive of brain arteriovenous malformation hemorrhage. Stroke 2014;45:1964–70 doi:10.1161/STROKEAHA.114.005170 pmid:24923721

   Abstract/FREE Full Text
9. 9.↵
   1. Stein K-P,
   2. Wanke I,
   3. Forsting M, et al

   . Associated aneurysms in supratentorial arteriovenous malformations: impact of aneurysm size on haemorrhage. Cerebrovasc Dis 2015;39:122–29 doi:10.1159/000369958 pmid:25660640

   CrossRefPubMed
10. 10.↵
    1. Shakur SF,
    2. Liesse K,
    3. Amin-Hanjani S, et al

    . Relationship of cerebral arteriovenous malformation hemodynamics to clinical presentation, angioarchitectural features, and hemorrhage. Neurosurgery 2016;63:136–40 doi:10.1227/NEU.0000000000001285 pmid:27399378

    CrossRefPubMed
11. 11.↵
    1. Chen X,
    2. Cooke DL,
    3. Saloner D, et al

    . Higher flow is present in unruptured arteriovenous malformations with silent intralesional microhemorrhages. Stroke 2017;48:2881–84 doi:10.1161/STROKEAHA.117.017785 pmid:28855391

    Abstract/FREE Full Text
12. 12.↵
    1. Shakur SF,
    2. Hussein AE,
    3. Amin-Hanjani S, et al

    . Cerebral arteriovenous malformation flow is associated with venous intimal hyperplasia. Stroke 2017;48:1088–91 doi:10.1161/STROKEAHA.116.015666 pmid:28235957

    Abstract/FREE Full Text
13. 13.↵
    1. Norris JS,
    2. Valiante TA,
    3. Wallace MC, et al

    . A simple relationship between radiological arteriovenous malformation hemodynamics and clinical presentation: a prospective, blinded analysis of 31 cases. J Neurosurg 1999;90:673–79 doi:10.3171/jns.1999.90.4.0673 pmid:10193612

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Feghali J,
    2. Yang W,
    3. Xu R, et al

    . R2eD AVM score. Stroke 2019;50:1703–10 doi:10.1161/STROKEAHA.119.025054 pmid:31167618

    CrossRefPubMed
15. 15.↵
    1. Raoult H,
    2. Bannier E,
    3. Maurel P, et al

    . Hemodynamic quantification in brain arteriovenous malformations with time-resolved spin-labeled magnetic resonance angiography. Stroke 2014;45:2461–64 doi:10.1161/STROKEAHA.114.006080 pmid:24984747

    Abstract/FREE Full Text
16. 16.↵
    1. Lin TM,
    2. Yang HC,
    3. Lee CC, et al

    . Stasis index from hemodynamic analysis using quantitative DSA correlates with hemorrhage of supratentorial arteriovenous malformation: a cross-sectional study. J Neurosurg 2019 April 26. [Eub ahead of print] doi:10.3171/2019.1.JNS183386 pmid:31026828

    CrossRefPubMed
17. 17.↵
    1. Burkhardt JK,
    2. Chen X,
    3. Winkler EA, et al

    . Delayed venous drainage in ruptured arteriovenous malformations based on quantitative color-coded digital subtraction angiography. World Neurosurg 2017;104:619–27 doi:10.1016/j.wneu.2017.04.120 pmid:28457930

    CrossRefPubMed
18. 18.↵
    1. Rivera R,
    2. Sordo JG,
    3. Echeverria D, et al

    . Quantitative evaluation of arteriovenous malformation hemodynamic changes after endovascular treatment using parametric color coding: a case series study. Interv Neuroradiol 2017;23:650–55 doi:10.1177/1591019917721867 pmid:28764614

    CrossRefPubMed
19. 19.↵
    1. Strother CM,
    2. Bender F,
    3. Deuerling-Zheng Y, et al

    . Parametric color coding of digital subtraction angiography. AJNR Am J Neuroradiol 2010;31:919–24 doi:10.3174/ajnr.A2020 pmid:20167651

    Abstract/FREE Full Text
20. 20.↵
    1. Klein DK

    . KAPPAETC: Stata Module to Evaluate Interrater Agreement. Boston College Department of Economics. 2019. https://econpapers.repec.org/software/bocbocode/s458283.htm. Accesssd October 03, 2020.
21. 21.↵
    1. Ruedinger KL,
    2. Harvey EC,
    3. Schafer S, et al

    . Optimizing the quality of 4D-DSA temporal information. AJNR Am J Neuroradiol 2019;40:2124–29 doi:10.3174/ajnr.A6290 pmid:31672837

    Abstract/FREE Full Text
22. 22.↵
    1. Huo R,
    2. Fu W,
    3. Li H, et al

    . RNA sequencing reveals the activation of Wnt signaling in low flow rate brain arteriovenous malformations. J Am Heart Assoc 2019;8:e012746 doi:10.1161/JAHA.119.012746 pmid:31170876

    CrossRefPubMed
23. 23.↵
    1. Peacock HM,
    2. Tabibian A,
    3. Criem N, et al

    . Impaired SMAD1/5 mechanotransduction and Cx37 (connexin 37) expression enable pathological vessel enlargement and shunting. Arterioscler Thromb Vasc Biol 2020;40:e87–104 doi:10.1161/ATVBAHA.119.313122 pmid:32078368

    CrossRefPubMed
24. 24.↵
    1. Cebral JR,
    2. Mut F,
    3. Weir J, et al

    . Association of hemodynamic characteristics and cerebral aneurysm rupture. AJNR Am J Neuroradiol 2011;32:264–70 doi:10.3174/ajnr.A2274 pmid:21051508

    Abstract/FREE Full Text
25. 25.↵
    1. Sforza DM,
    2. Kono K,
    3. Tateshima S, et al

    . Hemodynamics in growing and stable cerebral aneurysms. J Neurointerv Surg 2016;8:407–12 doi:10.1136/neurintsurg-2014-011339 pmid:25653228

    Abstract/FREE Full Text
26. 26.↵
    1. Varble N,
    2. Rajabzadeh-Oghaz H,
    3. Wang J, et al

    . Differences in morphologic and hemodynamic characteristics for “PHASES-based” intracranial aneurysm locations. AJNR Am J Neuroradiol 2017;38:2105–10 doi:10.3174/ajnr.A5341 pmid:28912279

    Abstract/FREE Full Text
27. 27.↵
    1. Cebral J,
    2. Ollikainen E,
    3. Chung BJ, et al

    . Flow conditions in the intracranial aneurysm lumen are associated with inflammation and degenerative changes of the aneurysm wall. AJNR Am J Neuroradiol 2017;38:119–26 doi:10.3174/ajnr.A4951 pmid:27686488

    Abstract/FREE Full Text
28. 28.↵
    1. Viñuela F,
    2. Nombela L,
    3. Roach MR, et al

    . Stenotic and occlusive disease of the venous drainage system of deep brain AVM’s. J Neurosurg 1985;63:180–84 doi:10.3171/jns.1985.63.2.0180 pmid:4020440

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Kader A,
    2. Young WL,
    3. Pile-Spellman J, et al

    . The influence of hemodynamic and anatomic factors on hemorrhage from cerebral arteriovenous malformations. Neurosurgery 1994;34:801–08 doi:10.1227/00006123-199405000-00003 pmid:7914356

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Shakur SF,
    2. Amin-Hanjani S,
    3. Mostafa H, et al

    . Hemodynamic characteristics of cerebral arteriovenous malformation feeder vessels with and without aneurysms. Stroke 2015;46:1997–99 doi:10.1161/STROKEAHA.115.009545 pmid:25991417

    Abstract/FREE Full Text
31. 31.↵
    1. Illies T,
    2. Forkert ND,
    3. Saering D, et al

    . Persistent hemodynamic changes in ruptured brain arteriovenous malformations. Stroke 2012;43:2910–15 doi:10.1161/STROKEAHA.112.669945 pmid:23091120

    Abstract/FREE Full Text
32. 32.↵
    1. Todaka T,
    2. Hamada JI,
    3. Kai Y, et al

    . Analysis of mean transit time of contrast medium in ruptured and unruptured arteriovenous malformations. Stroke 2003;34:2410–14 doi:10.1161/01.STR.0000089924.43363.E3 pmid:12970520

    Abstract/FREE Full Text
33. 33.↵
    1. Shellikeri S,
    2. Bai H,
    3. Setser RM, et al

    . Association of intracranial arteriovenous malformation embolization with more rapid rate of perfusion in the peri-nidal region on color-coded quantitative digital subtraction angiography. J Neurointerv Surg 2020;12:902–05 doi:10.1136/neurintsurg-2019-015776pmid:32188762

    Abstract/FREE Full Text
34. 34.↵
    1. Ma GM,
    2. Dmytriw AA,
    3. Patel PA, et al

    . Quantitative color-coded digital subtraction neuroangiography for pediatric arteriovenous shunting lesions. Childs Nerv Syst 2019;35:2399–403 doi:10.1007/s00381-019-04289-8 pmid:31280353

    CrossRefPubMed
35. 35.↵
    1. Atkinson RP,
    2. Awad IA,
    3. Batjer HH, et al

    ; Joint Writing Group of the Technology Assessment Committee American Society of Interventional and Therapeutic Neuroradiology; Joint Section on Cerebrovascular Neurosurgery a Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons; Section of Stroke and the Section of Interventional Neurology of the American Academy of Neurology. Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke 2001;32:1430–42 doi:10.1161/01.STR.32.6.1430 pmid:11387510

    Abstract/FREE Full Text
36. 36.↵
    1. Iancu-Gontard D,
    2. Weill A,
    3. Guilbert F, et al

    . Inter- and intraobserver variability in the assessment of brain arteriovenous malformation angioarchitecture and endovascular treatment results. AJNR Am J Neuroradiol 2007;28:524–27 pmid:17353328

    Abstract/FREE Full Text
37. 37.↵
    1. Lin EY,
    2. Lee RC,
    3. Guo WY, et al

    . Three-dimensional quantitative color-coding analysis of hepatic arterial flow change during chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2018;29:1362–68 doi:10.1016/j.jvir.2018.04.012 pmid:30170947

    CrossRefPubMed
38. 38.↵
    1. Meijs M,
    2. Pegge S. A H,
    3. Murayama K, et al

    . Color-mapping of 4D-CTA for the detection of cranial arteriovenous shunts. AJNR Am J Neuroradiol 2019;40:1498–1504 doi:10.3174/ajnr.A6156] pmid:31395664

    Abstract/FREE Full Text